GlassScriptPhysician profile
Charles D Crigger
NPI 1386640662
$1,307.51
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.55 · 2020: $219 · 2021: $453 · 2022: $599.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $132.05 | 2021-2022 | |
| Amarin Pharma, INC. | $112.62 | 2021-2022 | |
| Mylan Specialty L.P. | $103.35 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.74 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.87 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.33 | 2021-2022 | |
| Novo Nordisk INC | $72.70 | 2021-2022 | |
| Optinose US, INC. | $66.41 | 2019-2020 | |
| Amgen INC. | $58.86 | 2020-2022 | |
| Glaxosmithkline, LLC. | $56.48 | 2021 | |
| Intersect Ent, INC. | $49.05 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $42.50 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.27 | 2021-2022 | |
| Janssen Biotech, INC. | $38.04 | 2020 | |
| Aerin Medical INC. | $35.31 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apria Healthcare LLC | $35.25 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $28.05 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $21.91 | 2022 | |
| Daiichi Sankyo INC. | $19.47 | 2021 | |
| Abbvie INC. | $16.98 | 2022 | |
| Sun Pharmaceutical Industries INC. | $15.30 | 2020 | |
| Sunovion Pharmaceuticals INC. | $15.05 | 2020 | |
| Lundbeck LLC | $12.82 | 2022 | |
| Boston Scientific Corporation | $12.69 | 2020 | |
| Medtronic USA, INC. | $12.36 | 2020 | |
| Genzyme Corporation | $12.33 | 2019 | |
| Ambu INC. | $9.72 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Crigger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.